PharmGather Launches June Nucleic Acid Therapeutics Webinar Series: AI-Driven Molecular Design and DMPK In Vivo Evaluation

Jun 18, 2026 22:15 CST Updated 22:15

XtalPi

Computation-Driven Innovative Drug R&D Provider

Nucleic acid therapeutics, as the third wave of innovative pharmaceuticals, continue to break through “undruggable” targets, with an explosive growth in pipelines for genetic diseases, metabolic disorders, and oncology. However, challenges such as difficult-to-control off-target effects of siRNA sequences, poor in vivo metabolic stability, and an imperfect preclinical DMPK evaluation system continue to constrain project advancement.

Yadu’s Flagship Creation5-Part Special Series on Nucleic Acid Drugs Live Broadcasts, covering the entire chain from AI-driven design, DMPK, and delivery systems to clinical regulatory submissions and industrialization. It brings together leading pharmaceutical companies and seasoned experts to deconstruct R&D pain points through real-world case studies. Free access for industry professionals!

Reserve Your Spot Early for Two Upcoming Major Live Streams

Session 1 | AI-Enabled siRNA Drug Design: Introduction and Practical Insights into the Kodexia Platform

⏰Live Broadcast Time: June 22, 2026 20:00-21:00

?‍?Lecturer: Gao Xiangrui | Director of the AI Drug Design Platform at XtalPi Technology Innovation Center, Head of Nucleic Acid Drug R&D at XtalPi

Ph.D. in Theoretical Physics from the Chinese Academy of Sciences; former Algorithm Expert at 360, with extensive expertise in the industrial application of AI algorithms. Spearheaded the development of an integrated AI-driven drug design platform for nucleic acids, antibodies, and peptides. Published multiple research outcomes in top-tier international conferences such as AAAI and AACR, accelerating the advancement of multiple siRNA pipelines.

Share Outline

1. Core Challenges in the Current R&D of siRNA Drugs

2. Kodexia Platform Technical Framework and End-to-End AI Design Capabilities

3. Case Studies of Platform Implementation in R&D and the Value of Cost Reduction and Efficiency Enhancement

4. Future Technological Trends in AI-Driven Nucleic Acid Drug Design

Session 2 | Drug Metabolism and Pharmacokinetics Studies of Oligonucleotide Therapeutics

⏰ Live Broadcast Time: June 25, 2026, 20:00-21:00

👨‍🏫 Lecturer: Dr. Cheng from Hongren Pharma

Ph.D. in Pharmaceutical Analysis from Tongji Medical College, Huazhong University of Science and Technology; Associate Professor and Master’s Supervisor at a university; Part-time Supervisor at multiple pharmaceutical colleges and universities; Young Committee Member of the Chinese Pharmacological Society and the Professional Committee of the Chinese Pharmaceutical Association; Visiting Scholar at Kanazawa University, Japan. Possesses 17 years of experience in bioanalysis and drug metabolism and pharmacokinetics (DMPK) research; has presided over six national-level fund projects; published more than 20 academic papers, including 13 SCI papers as first author or corresponding author; specializes in establishing preclinical in vivo evaluation systems for nucleic acid therapeutics.

Share Outline

1. Background on the Development of the Oligonucleotide Drug Industry and Molecular Characteristics

2. Core DMPK Characteristics and Research Framework for Oligonucleotide Therapeutics

3. Key Considerations and Practical Pitfalls to Avoid in Nucleic Acid DMPK Studies

4. Analysis of a Complete DMPK Study Case for Classic Nucleic Acid Drugs

What You Will Gain from the Complete Live Streaming Series

✅ Front-end Design: AI tools rapidly optimize siRNA sequences to reduce off-target risks and enhance molecular activity

✅ Preclinical Evaluation: Mastering Small Nucleic Acid-Specific DMPK Standards to Avoid Common Failures in Toxicology and Metabolism Studies

✅ End-to-End Knowledge: One-stop coverage of the entire nucleic acid R&D process, including delivery, regulatory submission, and manufacturing

✅ Practical Insights: Real-World Project Cases from Leading Enterprises to Help You Avoid R&D Pitfalls

✅ Expert Interaction: Live Q&A with Senior Experts in the Field of Nucleic Acid Therapeutics

Live Stream Reservation Portal

Click the video account link below to reserve your spot and secure access to the two core dedicated sessions: AI Design and DMPK!